eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
December 04 2024
People commonly adopt ketogenic diets with the goal of losing weight, but what about the other side of this: can keto help people – particularly those...
New research by Mark C. Houston, MD, MS, MSc, FACP, FAHA, FASH, FACN, FAARM, DABC, Director of the Hypertension Institute and Vascular Biology, provided a comprehensive, logical and in-depth approach to the treatment of heart disease. He stated “Approximately 80% of coronary heart disease (CHD) can be prevented by optimal nutrition, optimal exercise, optimal weight and body fat, mild alcohol intake, and avoiding smoking”. Houston calls these preventable reasons for coronary heart disease (CHD) “external insults” to the cardiovascular (CV) system. According to Houston, the underlying root cause for CHD is the overwhelming external insults to the CV system. The study revealed three clear finite responses to these external insults, which are vascular inflammation, vascular oxidative stress and vascular immune dysfunction.
Coronary heart disease and cardiovascular disease continue to be the leading causes for death in the US. New understanding, evaluation, prevention, and treatment strategies are required to allow for early identification, prevention and treatment of coronary heart disease and cardiovascular disease. This new paper presents strong evidence on approaches for revolutionizing the treatment of CHD.
Endothelial cell membranes are the primary line of defense to the external insults that lead to the pathophysiology of CHD. The ability for a cell to protect itself efficiently varies depending on the biological fatty acid makeup of the cell membrane with trans fats (TFA), saturated fats (SFA), monounsaturated fats (MUFA), or omega-3 fats (PUFA). Chronic insults to the cell membrane can result in vascular inflammatory, oxidative stress, and immune responses. The result is that the CV system can become deregulated and dysfunctional, damaging the CV system.
Houston outlined a wide range of top modifiable coronary heart disease risk factors (a brief summary of the 395 new and emerging risk factors) including vitamin and mineral deficiencies, lack of sleep, lack of exercise and stress. What's more, other interventions were discussed such as the "Portfolio Diet" that resulted in a reduction of low-density lipoprotein cholesterol (LDL-C) of 13.1%.
Houston concluded that revolutionizing the treatment of CHD, requires a new approach that “must address the underlying pathophysiology, CHD risk factors, mediators, and their downstream effects, as well as the three finite vascular responses. This will be achievable by using a combination of targeted personalized and precision treatments with genomics, proteomics, metabolomics, nutrition, nutraceutical supplements, vitamins, minerals, antioxidants, anti-inflammatory agents, anti-immunological agents and drugs.”
Related Biotics Research Products:
Submit this form and you'll receive our latest news and updates.
Concerning findings about the sugar alcohol xylitol were recently published in the European Heart Journal. There were se...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment